Demographic predictors of resource utilization for bleeding peptic ulcer disease: The Ontario GI Bleed Study

Journal of Clinical Gastroenterology

Volumn 29, Issue 2, 1999, Pages 165-170

  Marshall, John K ^a,b   Collins, Stephen M ^a   Gafni, Amiram ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Cost analysis; Hemorrhage; Peptic ulcer

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; COMORBIDITY; COST BENEFIT ANALYSIS; COST MINIMIZATION ANALYSIS; DEMOGRAPHY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL COST; HUMAN; MALE; PEPTIC ULCER; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; COSTS AND COST ANALYSIS; FEMALE; HEALTH RESOURCES; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; LINEAR MODELS; MALE; MIDDLE AGED; ONTARIO; PEPTIC ULCER HEMORRHAGE;

EID: 0032792875     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199909000-00013     Document Type: Article

References (28)

1. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995;90:206-10.
2. Rockall TA, Logan RFA, Devlin HB, et al. Incidence of and mortality from acute upper gastrointestinal hemorrhage in the United Kingdom. BMJ 1995;311:222-6.
3. Levine JS. Misoprostol and nonsteroidal anti-inflammatory drugs: a tale of effects, outcomes, and costs. Ann Intern Med 1995;123: 309-10.
4. Gabriel SE, Jaakkimainen RL, Bombardier C. The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events. Arthritis Rheum 1993; 36:447-59.
5. Maetzel A, Ferraz MB, Bombardier C. The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal anti-inflammatory drugs. Arthritis Rheum 1998;41:16-25.
6. Munoz E, Margolis IB, Wise L. Surgonomics: the cost of gastrointestinal hemorrhage, the indentifier concept. Am J Gastroenterol 1985;80:139-42.
7. Richter JM, Wang TC, Fawaz K, et al. Practice patterns and costs of hospitalization for upper gastrointestinal hemorrhage. J Clin Gastroenterol 1991;13:268-73.
8. Jiranek GJ, Kozarek RA, Brandabur JJ, et al. Hospital cost analysis of peptic ulcer hemorrhage. Gastroenterology 1995;110:A20. Abstract.
9. Quirk DM, Barry MJ, Aserkoff B, et al. Physician specialty and variations in the cost of treating patients with acute upper gastrointestinal bleeding. Gastroenterology 1997;113:1443-8.
10. Rouleau JL, Moye LA, Pfeffer MA, et al. A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med 1993;328:779-84.
11. Redelmeier DA, Fuchs VR. Hospital expenditures in the United States and Canada. N Engl J Med 1993;328:772-8.
12. Fuchs VR, Hahn JS. How does Canada do it? A comparison of expenditures for physicians' services in the United States and Canada. N Engl J Med 1990;323:884-90.
13. Cooper GS, Chak A, Harper DL, et al. Care of patients with upper gastrointestinal hemorrhage in academic medical centers: a community-based comparison. Gastroenterology 1996;111:385-90.
14. Rosenthal GE, Harper DL, Quinn LM, et al. Severity-adjusted mortality and length of stay in teaching and nonteaching hospitals JAMA 1997;278:485-90.
15. Ontario Ministry of Health and Ontario Hospital Association. Ontario Case Cost Project: Ontario guide to case costing. Version 1.1. Toronto, Ontario: Ontario Ministry of Health and Ontario Hospital Association, 1995.
16. Canadian Institute for Health Information. Guidelines for management information systems in Canadian health care facilities. 1985: Ottawa, Ontario, Canada.
17. Drummond DF, Bloom BS, Carrin G, et al. Issues in the cross-national assessment of health care technology. Int J Technol Assess Health Care 1992;8:671-82.
18. Heyland DK, Kernerman P, Gafni A, et al. Economic evaluations in the critical care literature: do they help us improve the efficiency of our unit? Crit Care Med 1996;24:1591-8.
19. Longstreth GF, Feitelberg SP. Successful outpatient management of acute upper gastrointestinal hemorrhage: use of practice guidelines in a large patient series. Gastrointest Endosc 1998;47:219-22.
20. Hay JA, Lyubashevsky E, Elashoff J, et al. Upper gastrointestinal hemorrhage clinical guideline: determining the optimal hospital length of stay. Am J Med 1996;100:313-22.
21. Hsu P-I, Lai K-H, Lin X-H, et al. When to discharge patients with bleeding peptic ulcers: a prospective study of residual risk of rebleeding. Gastrointest Endosc 1996;44:382-7.
22. Vreeburgt EM, Snel P, de Bruijne JW, et al. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol 1997;92:236-43.
23. Soplepmann J, Peetsalu A, Peetsalu M, et al. Peptic ulcer hemorrhage in Tartu County, Estonia: epidemiology and mortality risk factors. Scand J Gastroenterol 1997;32:1195-200.
24. Llorente MJ, Del Val A, Tenias JM, et al. The clinical outcome of upper gastrointestinal bleeding in elderly differs from young patients. Gut 1997;41:A85. Abstract.
25. Dharmarajan TS, Zergabachew A, Kanagala M, et al. Association of age and adverse outcome in gastrointestinal bleeding: analysis of 255 hospitalized adults. Am J Gastroenterol 1997;92:1741. Abstract.
26. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized double-blind placebo-controlled trial. Ann Intern Med 1995; 123:241-9.
27. Rockall T. Risk assessment in upper gastrointestinal hemorrhage. Endoscopy 1997;29:E13. Abstract.
28. Nikolopoulou V, Thomopoulos K, Katsakoulis E, et al. Pharmaceutical versus nonpharmaceutical acute upper gastrointestinal bleeding. Gut 1996;39:A231. Abstract.